Literature DB >> 30585552

Age at First Osteoporosis Screening Among Older Women and Men: Is Bone Mineral Density Measurement Ordered Timely?

Ilker Tasci1, Bilgin Bahadir Basgoz1, Umit Cintosun2, Umut Safer3, Mehmet Ilkin Naharci4.   

Abstract

BACKGROUND: US National Osteoporosis Foundation has specified age cut-offs for osteoporosis screening in older women and men.
OBJECTIVE: In this study, we investigated whether Turkish seniors undergo their first ever osteoporosis screening early, on time or late.
METHODS: We determined the age of older women and men at their first-time Bone Mass Densitometry (BMD) testing using the medical records of a geriatric outpatient unit. The timing of the BMD test was considered ''late'' when performed after the age of 65 and 70 in women and men, respectively. An "early" screening was defined as having a BMD measurement before these age cut-offs.
RESULTS: We included 481 individuals in the study (mean age: 74.5±6.5 years, women: 62%). On admission, around 18% of the sample could give no definite information and another 35% had never been assessed for osteoporosis. Among those with a past screening, 64.8% reported comorbid osteoporosis and 33% reported no osteoporosis. Mean age of the first-time BMD measurement was 67.4±7.7 years. The first-time BMD measurement was on time in 9.7%, early in 37.4% and late in 52.9% of the subjects. Half of the individuals with a self-reported osteoporosis diagnosis were non-osteoporotic on a new BMD ordered following the geriatric assessment. Multimorbidity (≥3), parental hip fracture, and smoking were the independent predictors of being early screened.
CONCLUSION: We found two-thirds of women and men unscreened for osteoporosis despite being indicated by age. Early and late screening were both prevalent. Self-reported osteoporosis diagnosis was mostly inconsistent with BMD testing in our sample. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  DEXA; Osteoporosis; bone mineral density; comprehensive geriatric assessment; elderly; screening.

Year:  2019        PMID: 30585552     DOI: 10.2174/1871530319666181226125756

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  2 in total

1.  Low bone density and osteoporosis among older adults with Alzheimer's disease, vascular dementia, and mixed dementia: A Cross-sectional Study With Prospective Enrollment.

Authors:  Bilgin Başgöz; Semra İnce; Umut Safer; Mehmet İlkin Naharcı; İlker Taşçı
Journal:  Turk J Phys Med Rehabil       Date:  2020-05-18

2.  Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.

Authors:  Alexus D Kolb; Alison B Shupp; Dimpi Mukhopadhyay; Frank C Marini; Karen M Bussard
Journal:  Breast Cancer Res       Date:  2019-02-27       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.